XML 433 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - EUR (€)
€ in Millions, shares in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Total net sales € 32,667.3 € 28,262.9 € 27,558.5
Total cost of sales [1] (15,409.3) (13,770.9) (13,422.4)
Gross profit 17,258.0 14,492.0 14,136.1
Research and development (R&D) costs (4,698.8) (4,303.7) (3,980.6)
Selling, general and administrative (SG&A) costs (1,257.8) (1,165.7) (1,113.2)
Income from operations 11,301.4 9,022.6 9,042.3
Interest and other, net 104.7 19.8 41.2
Income before income taxes 11,406.1 9,042.4 9,083.5
Income tax expense (2,013.4) (1,680.6) (1,435.8)
Income after income taxes 9,392.7 7,361.8 7,647.7
Profit from equity method investments 216.7 209.8 191.3
Net income € 9,609.4 € 7,571.6 € 7,839.0
Basic net income per ordinary share (in EUR per share) € 24.73 € 19.25 € 19.91
Diluted net income per ordinary share (in EUR per share) € 24.71 € 19.24 € 19.89
Number of ordinary shares used in computing per share amounts:      
Basic (in shares) 388.5 393.3 393.8
Diluted (in shares) 388.9 393.6 394.1
Net system sales      
Total net sales € 24,474.3 € 21,768.7 € 21,938.6
Total cost of sales (11,384.0) (10,406.9) (10,151.0)
Net service and field option sales      
Total net sales 8,193.0 6,494.2 5,619.9
Total cost of sales € (4,025.3) € (3,364.0) € (3,271.4)
[1] Cost of sales includes amounts with related parties of €3,503.1 million, €2,793.2 million and €2,854.5 million in 2025, 2024 and 2023, respectively.